We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Un premier extrait de cannabis médical approuvé au Portugal pour Tilray Medical CANTANHEDE, Portugal, 14 mars 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., ci-après « Tilray » ou la « Société »...
Tilray Medical erhält Zulassung für erstes medizinisches Cannabisextrakt in Portugal CANTANHEDE, Portugal, March 14, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. („Tilray“ oder das...
Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal CANTANHEDE, Portugal, March 14, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq:...
Tilray gibt internationales Cannabis-Update zum Meilenstein der deutschen Cannabis-Legalisierung Die Freigabe von Cannabis in Deutschland eröffnet neue Möglichkeiten für Tilray auf dem...
Tilray fait le point sur la législation internationale concernant le cannabis suite à la légalisation historique du cannabis par l’Allemagne La déclassification du cannabis en Allemagne ouvre la...
Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization Germany’s De-Scheduling of Cannabis Opens Path to New Opportunities for Tilray in Potential $3bn Medical...
Tilray Medical salue le Bundestag allemand et l’adoption historique de la loi sur le cannabis à usage médicinal en Allemagne La nouvelle loi allemande sur le cannabis à usage médicinal...
Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany New Medical Cannabis Act in Germany Provides Easier Access to Medical Cannabis for Patients Through...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions